What we do Advanced Enzyme Technologies Limited is India's largest enzyme company specializing in manufacturing and selling enzymes and probiotics for healthcare, nutrition, and industrial use globally. |
Founded in 1,989 |
Market share Largest domestic enzyme manufacturer with significant global presence and top positions in Indian enzyme markets. |
Problem solved Provides eco-friendly enzymatic solutions to replace chemicals in food processing, animal nutrition, pharmaceuticals, and bio-industrial applications. |
Top clients or who we serve Serves industries like human and animal nutrition, baking, pharmaceuticals, food & beverage, and specialty applications globally; B2B primarily. |
Key management Defers detailed key management information |
Our journey and innovations Founded in 1989, IPO in 2016, expanded via acquisitions in USA, Europe, and India, launched multiple innovative enzyme and probiotic products. |
Where we operate Operations across India, USA, Europe, Asia, and global exports with international subsidiaries in USA and Europe. |
Top products or what we offer Offers over 400 enzyme products and probiotics; flagship products include human nutrition, animal health, food and non-food enzymes. |
Top brands Includes Wellfa (B2C brand), Pepzyme Pro, SacchariSEB ML, and Code T-400 enhancing digestive health and food processing. |
Raw materials needed Primary inputs include fermentation raw materials, microbial cultures, and biotechnological ingredients. |
Raw materials supplier Supplied by various global vendors specializing in fermentation raw materials. |
Recurring vs cyclical contribution Majority of revenue is recurring, sourced from ongoing enzyme sales and contract manufacturing. |
Our industry position Among the top Indian enzyme companies with growing international footprint and diversified product portfolio. |
Financial highlights FY25 consolidated revenue ₹6,369 million; PAT ₹1,340 million; EBITDA ₹1,944 million; stable margins with 2% revenue growth YoY. |
Geographical revenue split 54% international sales including USA and Europe; 46% domestic India sales in FY25. |
Order book - |
Whats driving growth Growth driven by international expansion, new product launches, increasing demand in nutrition and bio-processing segments. |
Our future plans Focus on expanding global footprint, R&D investment, inorganic growth via acquisitions, and diversification into probiotics and bio-catalysis. |
Our green promise Investments in solar power and eco-friendly processes underline commitment to sustainability. |
Our people and values Over 750 employees worldwide fostering innovation, diversity, and safety culture. |
Key challenges ahead Competition, regulatory compliance, and maintaining R&D pipeline amid market volatility. |
Interesting facts First Indian enzyme company with global integrated manufacturing and significant international acquisitions. |
Risks and strategy Risk mitigation through diversification, technology focus, strong compliance, and expansions in high-growth segments. |
